Tudor Investment Corp Et Al / TEVA
Tudor Investment Corp Et Al’s Teva Pharmaceutical Inds Ltd Position
Does Tudor Investment Corp Et Al own Teva Pharmaceutical Inds Ltd (TEVA)? Yes — 544.5K shares worth $16M (+0.03% of its 13F portfolio) as of Q1 2026, up from 500.0K shares the prior filed quarter.
Position Value
$16M
Q1 2026
Shares
544.5K
% of Portfolio
+0.03%
Quarters Held
20
currently held
Position History TEVA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 544.5K | $16M | +0.03% |
| Q4 2025 | 500.0K | $16M | +0.03% |
| Q3 2025 | 650.0K | $13M | +0.02% |
| Q2 2025 | 650.0K | $11M | +0.02% |
| Q1 2025 | 697.5K | $11M | +0.04% |
| Q4 2024 | 450.0K | $10M | +0.04% |
| Q3 2024 | 815.0K | $15M | +0.05% |
| Q2 2024 | 855.0K | $14M | +0.07% |
| Q1 2024 | 945.0K | $13M | +0.08% |
| Q4 2023 | 956.3K | $10M | +0.08% |
| Q3 2023 | 894.5K | $9M | +0.09% |
| Q2 2023 | 685.7K | $5M | +0.06% |
| Q1 2023 | 1.16M | $10M | +0.16% |
| Q4 2022 | 1.15M | $10M | +0.21% |
| Q3 2022 | 1.13M | $9M | +0.20% |
| Q2 2022 | 1.12M | $8M | +0.22% |
| Q1 2022 | 700.1K | $7M | +0.15% |
| Q3 2020 | 10.2K | $92,000 | 0.00% |
| Q1 2020 | 10.1K | $91,000 | +0.01% |
| Q4 2019 | 10.6K | $104,000 | 0.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tudor Investment Corp Et Al’s full portfolio or all institutional holders of TEVA.